ACRO Biomedical Co., Ltd. (TPEX:6748)

Taiwan · Delayed Price · Currency is TWD

164.00

-23.00 (-12.30%)

Jul 29, 2026, 2:00 PM CST

ACRO Biomedical Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	38.26	38.26	44.23	51.06	27.63	21.83
Revenue Growth	4.81%	-13.51%	-13.38%	84.79%	26.59%	21.04%
Gross Profit	18.53	18.53	26.19	39.12	13.43	14.54
Operating Income	-92.22	-92.22	-64.65	-48.67	-62.78	-53.56
Net Income	-82.66	-82.66	-62.09	-41.42	-60.88	-50.78
Earnings Per Share	-1.35	-1.35	-1.01	-0.79	-1.29	-1.43
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
AGO Biomedical	38.12	38.12	42.32	49.44	27.45	21.83
Other	0.14	0.14	1.92	1.63	0.19	-
Total	38.26	38.26	44.23	51.06	27.63	21.83

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	977.87	977.87	498.95	579.23	316.85	62.97
Total Debt	10.59	10.59	15.85	21.1	10.92	13.32
Net Cash (Debt)	967.28	967.28	483.1	558.13	305.93	49.65
Net Cash Growth	119.80%	100.22%	-13.44%	82.43%	516.20%	-51.44%
Net Cash Per Share	15.79	15.79	7.89	10.59	6.46	1.40

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-49.01	-49.01	-43.38	-48.27	-45.15	-47.83
Capital Expenditures	-12.82	-12.82	-30.55	-21	-2.74	-0.37
Free Cash Flow	-61.83	-61.83	-73.93	-69.27	-47.89	-48.2
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	48.43%	48.43%	59.21%	76.60%	48.59%	66.62%
Operating Margin	-241.06%	-241.06%	-146.17%	-95.31%	-227.17%	-245.35%
Pretax Margin	-216.06%	-216.06%	-140.33%	-81.11%	-220.33%	-232.61%
Profit Margin	-216.06%	-216.06%	-140.37%	-81.11%	-220.33%	-232.61%
FCF Margin	-161.62%	-161.62%	-167.13%	-135.66%	-173.30%	-220.80%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	309.04	105.62	35.36	47.18	37.07	43.02